Improving prevention and early care for HIV-related cancers in East Africa
Official title: United States-East Africa HIV-Associated Malignancy Research Center (USEAHAMRC) for Career Development and the Prevention, Early Detection and Efficient Linkage to Care for Virus-related Cancers
Funded at University of California, San Francisco · NIH-11112369 · Data updated 2026-11-12
This program brings U.S. and East African teams together to prevent, find earlier, and speed access to treatment for people with HIV who face virus-related cancers like cervical cancer and Kaposi's sarcoma.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project start | July 13, 2020 |
| Project end | June 30, 2026 |
| Funding year | 2025 |
| Award (this year) | $560,167 |
| NIH project number | 5U54CA254571-06 |
| Project ID | NIH-11112369 on NIH RePORTER |
Who could benefit from this research
✓Could help
People living with HIV in East Africa—especially women at risk for cervical cancer and anyone with signs or risk of Kaposi's sarcoma—who can access participating clinics would be ideal candidates for the program's screening and linkage activities.
✕Less likely to help
People without HIV, those living outside the participating East African regions, or those with cancers not caused by viruses are unlikely to gain direct benefit from this center's activities.
What this research studies
The center builds a network linking eight institutions in the U.S. and East Africa to work on preventing and detecting cancers linked to viruses in people with HIV. It supports training and career development for emerging African investigators and U.S. junior researchers so local teams can lead studies. The program will run prevention and early-detection activities, improve diagnostic testing, and strengthen ways to connect people quickly to care. Research projects will be led by the newly trained local investigators and implemented at partner clinics in the region.
Why it matters
Potential benefit: If successful, this work could lead to earlier cancer detection, better prevention, and faster treatment connections that reduce illness and death among people with HIV in East Africa.
How similar studies have gone: Previous programs have shown that targeted screening and better linkage to care can improve outcomes for cervical cancer and Kaposi's sarcoma, while the combined emphasis on local investigator training and a regional research network is a newer approach.
Where this research is happening
-
University of California, San Francisco
San Francisco, United States Active
Researchers
- Principal investigator: Martin, Jeffrey N — University of California, San Francisco
- Study coordinator: Martin, Jeffrey N
Related research
Other NIH-funded projects on the same topics.
-
Detecting cancer risk and treatment response in NF1 nerve tumors using cfDNA markers
A doctor-led study will test blood-based DNA markers to detect when NF1-related nerve tumors become malignant and to monitor how well treatment is working.
-
Epigenetic Basis for Controlling Aggressive IDH-Mutant Gliomas
Aims to understand and shape the epigenetic changes in IDH-mutant brain tumors to restrain their growth, which could lead to new, targeted treatment options for patients.
-
US–East Africa center to prevent and detect virus-linked cancers in people with HIV
This program builds a US–East Africa research network to train local investigators and improve prevention, earlier detection, and faster connection to care for virus-related cancers in people with HIV.
-
U.S.–East Africa program to prevent, detect early, and link people with HIV-related cancers to care
This program brings U.S. and East African teams together to help people with HIV by improving prevention, earlier detection, and faster connection to care for cancers linked to the virus.
-
U.S.–East Africa center to prevent and find HIV-related cancers and speed connection to care
This program builds a U.S.–East Africa team to improve prevention, earlier detection, and faster linkage to care for people with HIV at risk for cervical cancer and Kaposi’s sarcoma.
-
Boosting TET Activity to Help Treat AML with Vitamin C
Vitamin C may help people with a type of blood cancer (AML) by boosting a natural anti-cancer pathway, potentially improving outcomes for adults with this disease.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.